Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Thomis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cardiovascular Drugs and Therapy|June 1, 1990
Encainide--an updated safety profileJ A Thomis
Lancet (London, England)|October 3, 1981
Sotalol and the Q-Tc intervalE A Lockhart, J A Thomis
European Journal of Clinical Pharmacology|October 1, 1980
Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiencyG Berglund, R Descamps, J A Thomis
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1982
Electrocardiographic changes after long-term treatment with sotalol in hypertensive patientsM Castro, R Descamps, J A Thomis
European Journal of Clinical Pharmacology|January 1, 1982
Comparison of once and twice daily sotalol in exercise-induced angina pectorisC Wilhelmsson, A Vedin, G Ulvenstam, et al.
British Journal of Clinical Pharmacology|February 1, 1982
Creatinine clearance, different methods of determinationJ A Thomis, H H Soep, T Hallynck, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Should clearance be normalised to body surface or to lean body mass?T H Hallynck, H H Soep, J A Thomis, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Lean body mass and amikacin dosageT H Hallynck, H H Soep, J A Thomis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cardiovascular Drugs and Therapy|June 1, 1990
Encainide--an updated safety profileJ A Thomis
Lancet (London, England)|October 3, 1981
Sotalol and the Q-Tc intervalE A Lockhart, J A Thomis
European Journal of Clinical Pharmacology|October 1, 1980
Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiencyG Berglund, R Descamps, J A Thomis
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1982
Electrocardiographic changes after long-term treatment with sotalol in hypertensive patientsM Castro, R Descamps, J A Thomis
European Journal of Clinical Pharmacology|January 1, 1982
Comparison of once and twice daily sotalol in exercise-induced angina pectorisC Wilhelmsson, A Vedin, G Ulvenstam, et al.
British Journal of Clinical Pharmacology|February 1, 1982
Creatinine clearance, different methods of determinationJ A Thomis, H H Soep, T Hallynck, et al.
British Journal of Clinical Pharmacology|May 1, 1981
Should clearance be normalised to body surface or to lean body mass?T H Hallynck, H H Soep, J A Thomis, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1980
Lean body mass and amikacin dosageT H Hallynck, H H Soep, J A Thomis, et al.
Pageof 1